Subsequently, the MRD status at HSCT, rather than the allelic ratio or co-mutational status at diagnosis—remained the most relevant prognostic factor in FLT3-ITD mutated AML patients undergoing allogeneic HSCT. Here, FLT3 is linked to acute myeloid leukemia.